Exchange: NASDAQ·Updated 11:53 AM EDT

APTO Aptose Biosciences Inc

$1.69
$0.015
(0.90%)
Today
Reported EarningsMay 13
Mkt Cap$4.31M
Vol636.00

About APTO

Aptose Biosciences is a biopharmaceutical company focused on the discovery, research and development of novel, first-in-class anticancer therapies with high safety profiles. Through its own discovery efforts, as well as partnering activities, Lorus is building a portfolio of promising anticancer drugs ranging from discovery and preclinical to clinical-proof-of concept stage. Lorus seeks suitable partners for subsequent late-stage registration trials and eventual commercialization.
48

Neutral Sentiment

How do you feel about APTO?

Advertisement|Remove ads.